| BCBS Massachusetts | Medicare Advantage Management | 2026-09-01 |
| HealthPartners | Pneumatic compression devices and heat/cold | 2026-09-01 |
| BCBS Highmark NY and West NY | Daratumumab (Darzalex) and Daratumumab and Hyaluronidase-fihj (Darzalex Faspro) | 2026-09-01 |
| BCBS Highmark NY and West NY | Nipocalimab-aahu (Imaavy) | 2026-09-01 |
| BCBS Highmark NY and West NY | Ocrelizumab (Ocrevus) and Ocrelizumab and hyaluronidase-ocsq (Ocrevus Zunovo) | 2026-09-01 |
| BCBS Highmark NY and West NY | Pegloticase (Krystexxa) | 2026-09-01 |
| BCBS Highmark Delaware | Natalizumab (Tysabri) and Natalizumab Biosimilars | 2026-09-01 |
| BCBS Highmark Delaware | Interleukin-23 Antagonists | 2026-09-01 |
| BCBS Highmark Delaware | Ocrelizumab (Ocrevus) and Ocrelizumab and hyaluronidase-ocsq (Ocrevus Zunovo) | 2026-09-01 |
| BCBS Highmark West Virginia | Natalizumab (Tysabri) and Natalizumab Biosimilars | 2026-09-01 |